-
admin
Posts
LD Carbon Closes $28M Investment to Scale Production of Sustainable Carbon Black and Pyrolysis Oil
Woven Capital leads Series C round to advance the circular economy by diverting used tires from landfills and supporting development of high-performance recycled car parts SEOUL,...
The Habit Burger Grill Opens 11th Restaurant in New Jersey With Hamilton Drive-Thru Location
The Habit Burger Grill to Open Its Doors to the Public on June 18 IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — The Habit Burger...
Crestline Selected to Manage the Hotel Indigo Asheville Downtown, NC
FAIRFAX, Va., June 18, 2024 (GLOBE NEWSWIRE) — Crestline Hotels & Resorts, LLC, announced today it has been selected to manage the Hotel Indigo Asheville...
Aerosol Valves Market Forecast at $2.4 Billion by 2030, Driven by the Use of Bio-based Polymers in the Packaging Industry
Dublin, June 18, 2024 (GLOBE NEWSWIRE) — The “Aerosol Valves – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market...
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
FLOW kidney outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 1.0 mg in people with type 2 diabetes1 SELECT cardiovascular outcomes trial data...
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will...
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic...
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with interim data expected by the...
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
– First Patient Dosed in Expanded Access Program and Enrollment Ongoing – IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON),...
Comviva introduces CNPaaS for advanced monetization with Network APIs
Unveils pioneering CNPaaS solution that shall enable advanced 5G network capabilities such as on-demand quality of service. New solution to allow businesses to control, configure, and...